BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL

  July 28, 2008

   · 

  3 min read
• Business

  Seegene, Inc. and Shimadzu Corporation Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution

  July 28, 2008

   · 

  1 min read
• Biotech Bay

  UVaCide Corp. an Emerging Leader in Medical Technology, Secures $6M in Capital

  July 28, 2008

   · 

  2 min read
• Drug Development

  OctoPlus Proves Efficacy of OP-145 in Phase II Ear Infection Study

  July 28, 2008

   · 

  1 min read
• Business

  Addex Pharmaceuticals Reports First Half 2008 Financial Results, Maiden Profit

  July 28, 2008

   · 

  1 min read
• Drug Development

  First Half 2008 Financial Results: NicOx SA Nears Completion of Phase 3 Naproxcinod Studies

  July 28, 2008

   · 

  1 min read
• Business

  Cytomedix Inc. Retains Dr. David F. Counts, Inventor of Company’s Anti-Inflammatory Peptide Patent

  July 28, 2008

   · 

  1 min read
• Business

  Hana Biosciences, Inc. Announces Conference Call On Second Quarter Financial Results and Business Update

  July 28, 2008

   · 

  1 min read
• Biotech Bay

  Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of ‘Start Clean’ Strategy

  July 28, 2008

   · 

  5 min read
• Genetown

  Generex Biotechnology Corporation Granted Additional Time to Comply With NASDAQ Listing Requirement

  July 28, 2008

   · 

  1 min read